ASNB - AdvanSource Biomaterials Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.1100
-0.0150 (-12.04%)
As of 9:30AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.1250
Open0.1100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1100 - 0.1100
52 Week Range0.0300 - 0.1500
Volume100
Avg. Volume43,451
Market Cap2.364M
Beta (3Y Monthly)2.26
PE Ratio (TTM)8.46
EPS (TTM)0.0130
Earnings DateFeb 19, 2019 - Feb 22, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
Trade prices are not sourced from all markets
  • Business Wire8 months ago

    AdvanSource Biomaterials Announces Multi-Year Extension of License and Royalty Agreement with Access Scientific

    AdvanSource Biomaterials Corporation (ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced that the Company has entered into a multi-million dollar amendment of the current supply, royalty and license agreement with Access Scientific, a San Diego-based healthcare company engaged in the business of developing vascular access devices that simplify and improve minimally invasive and infusion therapy procedures. It also has been extended to incorporate several Access Scientific product line extensions. This Amendment is the result of the efforts conducted by both organizations in the development of a specialized polymer and associated technique yielding significant results in unique anti-infective and anti-thrombogenic properties, which significantly reduce infection rates and deep vein thrombosis (DVT) and improve patient outcomes.

  • We're sorry this is all we were able to find about this topic.